Quintiles’ aims to raise $600m in IPO, but who else will sell?
This article was originally published in Scrip
Executive Summary
In a recent interview with Scrip, Dr Dennis Gillings, executive chairman and founder of Quintiles, waxed lyrical about the "luxury" of being a private company. However, according to the registration statement it filed with the US Securities and Exchange Committee (SEC) to raise $600 million in an initial public offering of common stock, the time has come to go public once again.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.